JW Pharmaceutical Corporation (KRX:001060)
South Korea
· Delayed Price · Currency is KRW 21,100
-1,300 (-5.80%)
At close: Mar 28, 2025, 3:30 PM KST
JW Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Net Income | 65,040 | 37,006 | 31,892 | -967.85 | -15,241 | Upgrade
|
| Depreciation & Amortization | 19,101 | 22,575 | 16,836 | 16,112 | 20,688 | Upgrade
|
| Loss (Gain) From Sale of Assets | -464.91 | 1,088 | -3.28 | 1,048 | 12.24 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1,476 | - | 4,821 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | -790.9 | -2,830 | 8,515 | 1,820 | - | Upgrade
|
| Loss (Gain) on Equity Investments | -1,387 | -621.06 | 1,349 | 1,149 | 1,924 | Upgrade
|
| Provision & Write-off of Bad Debts | -6,081 | -3,644 | 8,437 | 12,073 | 6,870 | Upgrade
|
| Other Operating Activities | 11,782 | 53,846 | -8,913 | 32,946 | 13,584 | Upgrade
|
| Change in Accounts Receivable | 29,965 | -4,734 | -4,312 | -41,566 | 45,208 | Upgrade
|
| Change in Inventory | -8,775 | 8,917 | -11,541 | -2,655 | -8,876 | Upgrade
|
| Change in Accounts Payable | -14,527 | -9,536 | 31,652 | 3,730 | 2,831 | Upgrade
|
| Change in Unearned Revenue | - | -153.66 | -53.5 | - | -199.22 | Upgrade
|
| Change in Other Net Operating Assets | -15,946 | -14,756 | -21,915 | -5,564 | -3,747 | Upgrade
|
| Operating Cash Flow | 79,392 | 87,157 | 56,764 | 18,124 | 63,054 | Upgrade
|
| Operating Cash Flow Growth | -8.91% | 53.54% | 213.20% | -71.26% | 13.55% | Upgrade
|
| Capital Expenditures | -8,313 | -27,286 | -9,919 | -7,467 | -12,387 | Upgrade
|
| Sale of Property, Plant & Equipment | 46.4 | 24.97 | 6.26 | 63,446 | 65.58 | Upgrade
|
| Cash Acquisitions | -138.7 | -12,005 | -40.88 | - | - | Upgrade
|
| Divestitures | - | - | - | 384.96 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -17,734 | -13,419 | -2,433 | -5,435 | -2,652 | Upgrade
|
| Investment in Securities | 31,725 | 8,260 | -26,344 | 1,078 | -61,955 | Upgrade
|
| Other Investing Activities | 358.72 | -6,355 | 267.37 | -44,541 | 501.19 | Upgrade
|
| Investing Cash Flow | 14,085 | -63,780 | -18,919 | -22,869 | -79,427 | Upgrade
|
| Short-Term Debt Issued | 104,737 | 227,876 | 110,896 | 75,323 | 94,683 | Upgrade
|
| Long-Term Debt Issued | 25,102 | 60,166 | 29,585 | 60,296 | 70,000 | Upgrade
|
| Total Debt Issued | 129,839 | 288,042 | 140,481 | 135,619 | 164,683 | Upgrade
|
| Short-Term Debt Repaid | -171,805 | -316,108 | -177,004 | -84,408 | -142,087 | Upgrade
|
| Long-Term Debt Repaid | -47,809 | -4,051 | -2,795 | -16,845 | -29,427 | Upgrade
|
| Total Debt Repaid | -219,613 | -320,159 | -179,799 | -101,254 | -171,515 | Upgrade
|
| Net Debt Issued (Repaid) | -89,774 | -32,117 | -39,318 | 34,365 | -6,831 | Upgrade
|
| Issuance of Common Stock | - | - | 10,000 | 398.47 | - | Upgrade
|
| Repurchase of Common Stock | -750.42 | -260.88 | -281.6 | -412.29 | -224.25 | Upgrade
|
| Common Dividends Paid | -9,665 | -8,814 | -7,352 | -7,149 | -6,954 | Upgrade
|
| Other Financing Activities | -0 | -54 | 44 | -0 | - | Upgrade
|
| Financing Cash Flow | -100,190 | -41,245 | -36,907 | 27,202 | -14,009 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1,234 | -120.69 | -406.38 | 458.72 | -1,031 | Upgrade
|
| Net Cash Flow | -5,479 | -17,989 | 531.45 | 22,915 | -31,413 | Upgrade
|
| Free Cash Flow | 71,079 | 59,871 | 46,845 | 10,657 | 50,667 | Upgrade
|
| Free Cash Flow Growth | 18.72% | 27.81% | 339.56% | -78.97% | 9.56% | Upgrade
|
| Free Cash Flow Margin | 9.88% | 8.00% | 6.84% | 1.76% | 9.26% | Upgrade
|
| Free Cash Flow Per Share | 3047.37 | 2515.25 | 2016.97 | 459.20 | 2182.01 | Upgrade
|
| Cash Interest Paid | 8,136 | 11,119 | 9,035 | 7,567 | 7,640 | Upgrade
|
| Cash Income Tax Paid | 16,587 | 13,335 | 31,621 | 863.42 | -1,417 | Upgrade
|
| Levered Free Cash Flow | 41,864 | 23,381 | 74,265 | -6,672 | 54,565 | Upgrade
|
| Unlevered Free Cash Flow | 48,135 | 31,232 | 80,132 | -2,087 | 59,307 | Upgrade
|
| Change in Net Working Capital | -3,373 | 11,032 | -37,842 | 24,577 | -54,485 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.